UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with a revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's, and Crohn's diseases. Read More
BSE Listed BCPL Railway Infrastructure Ltd. (BSE: 542057) announced its Results for Q4 FY21 and FY21 after the meeting of Board of Directors was held. The Board of Directors recommended a Dividend of 0.7 per share (7%) previous year 6%. Total pay-out ...
Moderna announced on Tuesday (local time) that their coronavirus vaccine was 90 per cent effective six months after a person receives their second dose. ...
Stars like Bill Hader, Lisa Kudrow, Ramy Youssef, Aidy Bryant, Ziwe Fumudoh and Patton Oswalt will assemble at the USC Comedy Festival, Volume 5, announced the festival organisers. ...
Lasa Supergenerics Limited, a vertically integrated group spanning the entire animal and human healthcare value chain has announced its financial results for the third quarter ended December 31, 2020 (Q3FY21). ...
Share India Securities Limited, one of India's leading hi- tech broking Company and financial service provider, announced strong financial results for the quarter and year ended March 31st 2020. ...